Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00B547ZY09 ORD 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.20 22.86% 1.075 1,954,211 14:36:35
Bid Price Offer Price High Price Low Price Open Price
1.00 1.15 1.125 0.875 0.875
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 0.58 -3.04 -0.85 5
Last Trade Time Trade Type Trade Size Trade Price Currency
16:04:45 O 44,000 1.14 GBX

Microsaic Systems (MSYS) Latest News (1)

More Microsaic Systems News
Microsaic Systems Takeover Rumours

Microsaic Systems (MSYS) Discussions and Chat

Microsaic Systems Forums and Chat

Date Time Title Posts
06/12/201913:35Microsaic Systems546
05/12/201910:29Microsaic Systems - 2018989
19/12/201812:51Microsaic - Another pump and dump disaster79
24/7/201811:24Microsaic - miniaturised chip-size scientific instruments11
24/7/201811:23Microsaic Systems - 20111,548

Add a New Thread

Microsaic Systems (MSYS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Microsaic Systems trades in real-time

Microsaic Systems (MSYS) Top Chat Posts

Microsaic Systems Daily Update: Microsaic Systems Plc is listed in the Software & Computer Services sector of the London Stock Exchange with ticker MSYS. The last closing price for Microsaic Systems was 0.88p.
Microsaic Systems Plc has a 4 week average price of 0.70p and a 12 week average price of 0.70p.
The 1 year high share price is 2.15p while the 1 year low share price is currently 0.70p.
There are currently 456,365,146 shares in issue and the average daily traded volume is 2,059,299 shares. The market capitalisation of Microsaic Systems Plc is £4,905,925.32.
garth: Dave, why are you in this one? I have had a look at it a couple of times. At circa £300K revenue and losses circa 5 times that they just look in trouble down the line. Being valued at cash doesnt help - if the cash is heading down the drain then the share price can reasonably be expected to do the same... What am I missing? G.
bones: Agreed, Dave. For example, I have a solid holding in AOR (also NY Boy has some I think) where developments are under way in healthcare devices and it’s a dead cert that major players have a watching brief, especially regarding the heart valve technology. The finals are due in a week or so. That should give us a progress report and the share price may do nothing (currently 55p) and might even decline but you never know when some kind of interest from a major gets announced. I am not expecting fireworks yet so it is not a recommendation to buy, but an example of the situation like MSYS and MED. The herd is also missing in action at AOR and I have never known it so quiet with hardly a trade in recent weeks. Them’s the markets, I guess!
bones: Dave, it means there is one less punter to sell when the share price starts its move north. In all likelihood, these same sellers will pay twice the price to get aboard again. ‘Twas ever thus.
bones: Two weeks ago, a massive amount (relative to market size) was wagered on MSYS. It is not entirely clear why as all the buyers were sold into by person or persons unknown but likely an institution. It has been common in recent times for small cap funds to be distressed sellers (Miton an obvious example) as punters pulled funds from open-ended vehicles post-Brexit and especially after the late 2018 market wobble. Hence many a time have we seen an institution bailing out wholesale giving a massive buy signal as an overhang clears just before news hits. In fact, see my chart of RENE a few posts back and much of that big volume day can be attributed to Invesco bailing out a 12% holding in full, with share price multiplying soon after. Exactly the same happened in 2017 with VRS (15% owner Odier Asset sold and price multiplied in the months after). Just in April, I know that an institution bailed from WEY at 5p. I was on that and it doubled within a month. Now, it appears likely a 5%+ holder has bailed from MSYS (although we haven’t been notified) in early June. What next? Look at that “bowl” forming in the MSYS 2 year chart in the header. It looks good for further progress.
bones: Yes, Dave, we cannot lose sight of the significance of Friday's action. It's not like punters were chasing a fast moving share price up. They were buying into a wall at 1.7p unchanged all day. Seller unloading but demand there to meet it. Proper buyers, not momentum chasers.
bones: Pennyfalls. 7 Jun '19 - 16:58 - 95 of 97 Just out of interest, fellas, does anyone hold here long enough to understand the back-story and why the shares crashes a few years ago from circa 50p? Was this the usual Phrama case of major dilution, early unproven tech etc? Just wondering what the (brief) story was that got it down to circa 1p from those heights? Valid question Pennyfalls, so I took a quick look through Companies House accounts and some RNS’s and it seems to me that since flotation in 2011, the company has perpetually made losses around £2M annually due to an inability to find sufficient sales for its traditional small molecule mass spectrometer technology whilst constantly spending on R&D to improve the products and look for new technological advances. Because of the losses, the company has also regularly made placings starting off in the early days around 30p to 40p per share but as losses built and strategies failed, placings became ever more dilutive due to a collapsing share price, culminating in the last placing at 2p last year which created more shares than already existed. No wonder then that the share price has gone from 50p to 1p! My general view is that, up to very recently, the management haven’t really been very good! There seemed to be the old founders who were hanging on but these were really academics who tried to commercialise out of the Imperial College, London. Boffins don’t make money, they research and discover things. However, it does seem that the old guard has eventually left the building, whether walked or pushed. There has been a regular turnover of other executives too in recent years, partly I expect in the vain hope of finding the right people to take this forward. That is never a happy scenario. I am new to this company but it seems there is some confidence that Glenn Tracey may just be the CEO to do it right. The company seems to be accelerating signing up distribution deals for its old MS products around the world whilst good technological progress is being made with the protein identification and bioprocessing areas using MSYS technology. As I see it, the share price has a lot of baggage to shed and that is proving hard to shake off but, whisper it quietly, maybe the stars are aligning with commercial successes coming thanks to a much less flabby, complacent management team?
bones: Finished off today with 1.5M to carry forward, all at 1.7p give or take rounding down by MM’s. That’s me done here so now a case of seeing if the technical set up follows through. Clearly the fundamentals seem to be building a head of steam. I’ve cut my WEY position in half over the last couple of days, for >100% profit in one month and a tasty holding to carry forward for future growth prospects. I would like to repeat that here - double up, cut half then run the rest. Not all of these work out but I like the set up with a distressed seller feeding us at the bottom just as the business and share price seem to be regaining traction.
dave4545: Added to header. 1. Why are Biologics so expensive ? Answer. Biologic agents are more expensive to make than chemical drugs like DMARDs. The materials needed to create them cost more, and the manufacturing process, which uses live organisms, is more complex MSYS paragraph "From the information obtained, Microsaic estimates that there are potentially substantial savings available for its customers by switching from traditional analysis methods to Microsaic's MiD(R) ProteinID technology" Sounds like massive world wide potential could be for this yet share price has barely budged on this exciting development.
robste: I don't see how anyone is taking profits or making money selling at these prices. It can only be a lack of patience in the share price causing this decline. In the past MSYS seems to have attracted more than its fair share of short term investors who buy in, wait for a spike, sell and then wait for the all selling to reduce the share price so that they can buy in cheaply again. They aren't interested in long term progression, just that there are numerous and regular spikes that they can profit from. Whilst we all do this to some extent, there is a saturation point at which the sheer volume of people rushing to sell the moment the share price turns blue, actually causes a decline of the share price that it can't recover from, and the spikes stop coming. Thats what I see happening here recently. The last couple of postive RNS announcements haven't caused the expected spike and the short term investors are now moving their money elsewhere. I don't see this as a negative thing. I feel that MSYS is a medium to long term investment, and maybe when the share price inevitably starts to rise again it will do so in a much better slow and steady increase rather the up and down to stand still activity we have experienced in recent times.
robste: Hi folks. First time poster here. I only have a modest investment in this share compared to some of you (25,000 shares @ 2.16p) but I've long since given up on trying to find some logic behind the share price. It seems to me that the share price no longer reflects the activities or potential of the company, but rather it reflects the way in which the shares are being traded. MSYS has become an ideal stock for short term investors, and the sheer volume of people hitting the sell button almost the very moment the share price turns blue, inevitably sees it tumble back down to a base price within 24 hrs of the company publishing positive news. The rush to sell is creating a virtual ceiling from which this share price cannot currently escape and its difficult to see how this might change in the short term. I notice that some companies are looking at share consolidation as a means of trying to break this cycle and reduce volatility. Oxford Biomedica I suppose being the most recent example. A different company in different circumtances I know, but they are doing a 50 to 1 consolidation, turning a 15p share price into a 750p share price. Does anyone think that consolidation might be an option here in the future?
Microsaic Systems share price data is direct from the London Stock Exchange
Your Recent History
Microsaic ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191208 10:10:39